Harvard Bioscience Inc reports results for the quarter ended in June - Earnings Summary

Harvard Bioscience

08/08/2023 14:31

* Harvard Bioscience Inc  HBIO.OQ  reported quarterly
adjusted
earnings of 4 cents​​ per share for the quarter ended in June.
The mean expectation of three analysts for the quarter was
for earnings of 6 cents per share.
    * Revenue fell 1.5% to $28.76 million from a year ago;
analysts
expected $29.65 million. 
    * Harvard Bioscience Inc's reported EPS for the quarter was
a loss
of 2 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Harvard Bioscience Inc shares had fallen by 17.7% this
quarter and gained 63.2% so far this year.
    * The company reported a quarterly loss of $980 thousand.
    * Wall Street's median 12-month price target for Harvard
Bioscience Inc is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 01:31 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      0.06           0.04           Missed
 Mar. 31 2023      0.05           0.06           Beat
 Dec. 31 2022      0.03           0.04           Beat
 Sep. 30 2022      0.07           -0.01          Missed